tiprankstipranks
Spero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
PremiumCompany AnnouncementsSpero Therapeutics’ Phase 3 Trial Meets Primary Endpoint
22d ago
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
Premium
The Fly
GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy
22d ago
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
Premium
The Fly
Spero Therapeutics, GSK announce Phase 3 PIVOT-PO trial met primary endpoint
22d ago
Spero Therapeutics Reports 2024 Financial Results and Updates
PremiumCompany AnnouncementsSpero Therapeutics Reports 2024 Financial Results and Updates
3M ago
Spero Therapeutics reports Q4 EPS (38c), consensus (31c)
Premium
The Fly
Spero Therapeutics reports Q4 EPS (38c), consensus (31c)
3M ago
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SPRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Spero Therapeutics downgraded at Evercore on lack of capital allocation clarity
PremiumThe FlySpero Therapeutics downgraded at Evercore on lack of capital allocation clarity
6M ago
Spero Therapeutics downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Spero Therapeutics downgraded to In Line from Outperform at Evercore ISI
6M ago
Spero Therapeutics downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Spero Therapeutics downgraded to Hold from Buy at TD Cowen
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100